Chronic myelogenous leukemia

Xem 1-10 trên 10 kết quả Chronic myelogenous leukemia
  • Chronic Myelogenous Leukemia: Treatment The therapy of CML is changing rapidly because we have a proven curative treatment (allogeneic transplantation) that has significant toxicity and a new targeted treatment (imatinib) with excellent outcome based on 5-year follow-up data. Therefore, physician experience and patient preference must be factored into the treatment selection process. Discussion of both treatment options with a patient is indicated. The decision should focus on the outcomes, risks, and toxicities of the various approaches.

    pdf5p thanhongan 07-12-2010 40 3   Download

  • Chronic Myelogenous Leukemia Incidence The incidence of chronic myelogenous leukemia (CML) is 1.5 per 100,000 people per year, and the age-adjusted incidence is higher in men than in women (2.0 versus 1.2). The incidence of CML increases slowly with age until the middle forties, when it starts to rise rapidly. CML incidence for males decreased slightly (4.4%) between 1997 and 2003 as compared to 1977–1997. Definition The diagnosis of CML is established by identifying a clonal expansion of a hematopoietic stem cell possessing a reciprocal translocation between chromosomes 9 and 22.

    pdf5p thanhongan 07-12-2010 28 2   Download

  • Bài giảng Những rối loạn tăng sinh tủy (Myeloproliferative neoplasms) trình bày những nội dung chính như: Bạch cầu mạn dòng tủy (chronic myelogenous leukemia: CML), đa hồng cầu nguyên phát (Polycythemia vera: PV), tăng tiểu cầu nguyên phát (Essential thrombocythemia: ET), tăng tiểu cầu nguyên phát (Essential thrombocythemia: ET). Mời các bạn cùng tham khảo.

    ppt57p tangtuy04 23-03-2016 19 4   Download

  • Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài:Gender and ethnic differences in chronic myelogenous leukemia prognosis and treatment response: a single-institution retrospective study

    pdf8p toshiba24 06-12-2011 27 3   Download

  • Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Activation of the hedgehog pathway in chronic myelogeneous leukemia patients

    pdf5p toshiba22 21-11-2011 29 2   Download

  • Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Improvement of platelet dysfunction in chronic myelogenous leukemia following treatment with imatinib: a case report...

    pdf4p thulanh25 07-12-2011 21 2   Download

  • The preparation of human karyotype for the first time in 1959 led to the identification of numerical aberrations in the following years associated with Down’s, Turner and Klinefelter syndromes which implied the need for routine screening for chromosomal anomalies in certain clinical conditions.

    pdf512p conquynho32 15-09-2012 39 6   Download

  • Learners enrolled in all healthcare training programs need to have a basic understanding of medical genetics so that they can successfully transition from students to clinicians. The field of medical genetics is advancing at a fast pace and is becoming increasingly integral to all aspects of medicine. This fact emphasizes the need for every practicing clinician and faculty member to develop an in-depth knowledge of the principles of human genetics, given that they are applicable to such a wide variety of clinical presentations.

    pdf249p bachduong1311 07-12-2012 22 5   Download

  • The differential diagnostic possibilities are much fewer when the spleen is "massively enlarged," palpable more than 8 cm below the left costal margin or its drained weight is ≥1000 g (Table 60-3). The vast majority of such patients will have non-Hodgkin's lymphoma, chronic lymphocytic leukemia, hairy cell leukemia, chronic myelogenous leukemia, myelofibrosis with myeloid metaplasia, or polycythemia vera.

    pdf5p konheokonmummim 03-12-2010 27 3   Download

  • Table 79-3 Representative Oncogenes at Chromosomal Translocations Gene (Chromosome) Translocation Malignancy ABL BCR (22q11) (9q34.1)– (9;22)(q34;q11) Chronic myelogenous leukemia ATF1 EWS (22q12) (12q13)– (12;22)(q13;q12) Malignant melanoma of soft parts (MMSP) BCL1 IgH (14q32) (11q13.3)– (11;14)(q13;q32) Mantle lymphoma cell BCL2 IgH (14q32) (18q21.

    pdf5p konheokonmummim 03-12-2010 34 3   Download


Đồng bộ tài khoản